INTRODUCTION: The Institute of Medicine (IOM) 2011 on dietary references intakes for calcium and vitamin D specified that a 25-hydroxyvitamin D (25OHD) level below 30 nmol/L indicated risk of deficiency and that a level above 125 nmol/L indicated risk of harm. METHODS: We noted a high prevalence of hypovitaminosis D (23.9 %) and a substantive prevalence of hypervitaminosis D (4.8 %) in a retrospective audit of clinical samples (n = 10,181) obtained over 10 months in 2013. CONCLUSION: Hypovitaminosis D should be corrected by low dose supplementation (5 µg or 200 IU daily) with some at-risk groups needing higher doses (10 µg or 400 IU daily) based on 25OHD levels. Whereas, those taking high-dose vitamin D supplements based on mistaken beliefs about recently authorised claims of benefit for muscle function and misleading unauthorised claims need to be alerted to the potential harms of excessive supplementation.
INTRODUCTION: The Institute of Medicine (IOM) 2011 on dietary references intakes for calcium and vitamin D specified that a 25-hydroxyvitamin D (25OHD) level below 30 nmol/L indicated risk of deficiency and that a level above 125 nmol/L indicated risk of harm. METHODS: We noted a high prevalence of hypovitaminosis D (23.9 %) and a substantive prevalence of hypervitaminosis D (4.8 %) in a retrospective audit of clinical samples (n = 10,181) obtained over 10 months in 2013. CONCLUSION: Hypovitaminosis D should be corrected by low dose supplementation (5 µg or 200 IU daily) with some at-risk groups needing higher doses (10 µg or 400 IU daily) based on 25OHD levels. Whereas, those taking high-dose vitamin D supplements based on mistaken beliefs about recently authorised claims of benefit for muscle function and misleading unauthorised claims need to be alerted to the potential harms of excessive supplementation.
Authors: Jennifer M Walsh; Ciara A McGowan; Mark Kilbane; Malachi J McKenna; Fionnuala M McAuliffe Journal: Reprod Sci Date: 2012-09-11 Impact factor: 3.060
Authors: Kevin D Cashman; Tom R Hill; Alice A Cotter; Colin A Boreham; Werner Dubitzky; Liam Murray; Jj Strain; Albert Flynn; Paula J Robson; Julie Mw Wallace; Mairead Kiely Journal: Am J Clin Nutr Date: 2008-04 Impact factor: 7.045
Authors: Tom R Hill; Alice A Cotter; Sarah Mitchell; Colin A Boreham; Werner Dubitzky; Liam Murray; J J Strain; Albert Flynn; Paula J Robson; Julie M W Wallace; Mairead Kiely; Kevin D Cashman Journal: Br J Nutr Date: 2008-01-15 Impact factor: 3.718
Authors: C Toher; K Lindsay; M McKenna; M Kilbane; S Curran; L Harrington; O Uduma; F M McAuliffe Journal: J Hum Nutr Diet Date: 2013-08-24 Impact factor: 3.089
Authors: Roberta A McCarthy; Malachi J McKenna; Oyinkansola Oyefeso; Ogenna Uduma; Barbara F Murray; Jennifer J Brady; Mark T Kilbane; John F Murphy; Anne Twomey; Colm P O' Donnell; Nuala P Murphy; Eleanor J Molloy Journal: Br J Nutr Date: 2012-11-27 Impact factor: 3.718
Authors: A Catharine Ross; JoAnn E Manson; Steven A Abrams; John F Aloia; Patsy M Brannon; Steven K Clinton; Ramon A Durazo-Arvizu; J Christopher Gallagher; Richard L Gallo; Glenville Jones; Christopher S Kovacs; Susan T Mayne; Clifford J Rosen; Sue A Shapses Journal: J Clin Endocrinol Metab Date: 2010-11-29 Impact factor: 5.958
Authors: Maeve Smith; Eileen C O'Brien; Goiuri Alberdi; Aisling A Geraghty; Mark Kilbane; Malachi J McKenna; Fionnuala M McAuliffe Journal: Ir J Med Sci Date: 2019-08-29 Impact factor: 1.568
Authors: Malachi J McKenna; Oonagh C Lyons; Mary At Flynn; Rachel K Crowley; Patrick J Twomey; Mark T Kilbane Journal: BMJ Open Date: 2022-08-04 Impact factor: 3.006